SpaceX to Tell NASA the Moon Will Have to Wait

A leaked SpaceX schedule shows the company now expects the Starship Human Landing System to put astronauts on the Moon no earlier than September 2028, missing NASA’s mid-2027 Artemis 3 target; key interim milestones include an in‑orbit propellant transfer in June 2026 and an uncrewed HLS lunar landing in June 2027. The plan faces substantial execution risk because Starship has not yet achieved a fully successful orbital flight and SpaceX must still field the larger V2 vehicle slated for early 2026. With NASA having reopened the Artemis 3 contract and issued RFIs, Blue Origin’s advancing Blue Moon MK2 and recent New Glenn progress make SpaceX’s hold on the mission increasingly vulnerable and raise the prospect of schedule and procurement shifts for the Artemis program.

Analysis

A leaked SpaceX internal schedule reported by Politico shifts the earliest crewed Starship Human Landing System (HLS) lunar landing to September 2028, more than a year past NASA’s mid‑2027 Artemis 3 target. The document lists key interim milestones including an in‑orbit propellant transfer in June 2026 and an uncrewed HLS lunar landing in June 2027, and notes SpaceX plans to debut the larger Starship V2 in early 2026; Politico cites a congressional aide calling the 2028 objectives “very aggressive.”

NASA reopened the Artemis 3 contract in October to other providers and will issue an RFI and convene subject matter experts, increasing procurement risk for SpaceX’s sole‑source advantage. Blue Origin’s Blue Moon MK2 is already contracted for Artemis 5, aims to demonstrate an uncrewed lander in January 2026, and New Glenn’s recent successful test flight heightens the competitive threat to SpaceX for Artemis 3.

The schedule revision materially raises execution risk for the Artemis timeline and for firms whose revenue or valuation assumptions depend on a 2027 moon landing, while near‑term catalysts include SpaceX’s December integrated master schedule submission to NASA and the June 2026 propellant transfer attempt. Market sentiment in the signals is moderately negative and the situation warrants milestone‑linked reassessment rather than assuming the leaked dates will be met without slippage.

Key Decisions for Investors

• Monitor the December integrated master schedule submission and the June 2026 in‑orbit propellant transfer as primary technical/deal catalysts and reprice exposure if those milestones are missed
• Reduce concentrated exposure to companies or funds that have revenue assumptions tied to a 2027 Artemis 3 landing and implement downside hedges pending demonstration of Starship orbital success
• Watch Blue Origin’s January 2026 uncrewed MK2 objective and New Glenn test program as potential procurement catalysts that could redirect NASA spending, and be prepared to reallocate toward contractors that demonstrably benefit from a shift
• Set clear, milestone‑based stop‑loss or review triggers (post‑December schedule, post‑June 2026 test) rather than relying on the new September 2028 target as a firm delivery date